Wells Fargo's low accuracy and outlier call reduce conviction — but the negative EPS revision trend (13 down in 30 days) and 57% short interest suggest downside risk remains. Traders should consider the heavy short as a potential squeeze catalyst if earnings (due soon, no date given) surprise positively.
Price Chart
Executive Summary
Wells Fargo double-downgraded Doximity (DOCS) from Equal-Weight to Underweight on Aug 10, 2026, maintaining an $18 price target, implying 34% downside from the current $27.40. The firm's accuracy on DOCS is just 50% (3 of 6 calls), with a below-average track record. Consensus is mixed: 14 Buy, 13 Hold, 1 Sell among 28 analysts; the mean PT is $24.89 (9% downside). The downgrade is contrarian — only 1 analyst rates it Sell — but comes amid a broader negative EPS revision trend (13 downward revisions in 30 days, 1 upward). Insider selling is modest (~$88k total) but aligns with this bearish call. No congressional trades on record. Institutional activity is split, with VICTORY CAPITAL adding 41.5% while Baillie Gifford nearly exited (-83.2%). Short interest at 56.9% of float signals heavy bearish positioning. Bottom line: Wells Fargo's low accuracy and consensus-aligned target suggest this downgrade alone is not a game-changer, but the negative EPS momentum and high short interest warrant caution for longs.
Impact Score
Consensus & Targets
Among 28 analysts: 5 Strong Buy, 9 Buy (50% bullish), 13 Hold (46%), 1 Sell (4%). The consensus is tilted neutral-to-bullish, making Wells Fargo's Underweight a clear outlier.
Current PT: Wells Fargo $18 (low of all). Mean consensus $24.89, median $23.50, high $47. Current price $27.40 implies 9% downside to mean and 34% downside to Wells Fargo's target. Wells Fargo's $18 sits 28% below the consensus mean and is the lowest target on the Street — 62% below the high of $47.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-10 | Wells Fargo | downgrade | Underweight | $18.00 |
| 2026-08-07 | JP Morgan | maintain | Neutral | $31.00 |
| 2026-08-07 | Piper Sandler | reiterate | Overweight | $47.00 |
| 2026-08-07 | Evercore ISI Group | maintain | In-Line | $40.00 |
| 2026-06-29 | B of A Securities | downgrade | Underperform | $20.00 |
| 2026-05-15 | Goldman Sachs | maintain | Neutral | — |
| 2026-05-15 | Barclays | downgrade | Equal-Weight | — |
| 2026-05-14 | Leerink Partners | maintain | Outperform | — |
| 2026-05-14 | Jefferies | downgrade | Hold | — |
| 2026-05-14 | Canaccord Genuity | maintain | Buy | — |
In the past 30 days: 0 upgrades, 1 downgrade (Wells Fargo). EPS revisions over 30 days heavily negative: 13 downward vs 1 upward for the +1y period; 1 down vs 1 up for 0y period. Near-term (+1q) shows 2 upward revisions vs 0 down — a possible bright spot. The trend is clearly bearish for the next fiscal year.
Firm Track Record — Wells Fargo
Wells Fargo accuracy: 54% on 6027 calls | avg return: 3.5%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 14 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Truist Securities | 100% | 5/5 | 29% | top tier |
| JP Morgan | 83% | 5/6 | 14.5% | top tier |
| Barclays | 75% | 3/4 | 15.8% | top tier |
| Goldman Sachs | 75% | 3/4 | 4.1% | top tier |
| Evercore ISI Group | 71% | 5/7 | 6.4% | top tier |
| Mizuho | 67% | 2/3 | 6.8% | top tier |
| B of A Securities | 60% | 3/5 | 12.9% | above average |
| Keybanc | 60% | 3/5 | 3% | above average |
| Needham | 60% | 3/5 | 14.1% | above average |
| Wells Fargo | 50% | 3/6 | 11.4% | below average |
Wells Fargo has a 54% accuracy rate on 6,027 total calls (all stocks) with a 3.5% avg return — below average for DOCS. On DOCS specifically, 50% correct (3 of 6). Top-tier firms on DOCS include Truist (100%, 5 of 5, +29% avg), JP Morgan (83%, 5 of 6, +14.5%), and Barclays (75%, 3 of 4, +15.8%). Worst: Canaccord Genuity (29%, 2 of 7, -3.8%) and Morgan Stanley (33%, 2 of 6, +21.6%).
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1y | $1.58 | $1.32 — $1.78 | $716.0M | ↑1 ↓0 |
| 0y | $1.37 | $1.23 — $1.48 | $673.2M | ↑1 ↓0 |
| +1q | $0.42 | $0.37 — $0.46 | $195.4M | ↑2 ↓0 |
| 0q | $0.36 | $0.32 — $0.39 | $170.7M | ↑1 ↓0 |
Cross-Platform Signals
Insider trades: two small sells by Sitaram Siddharth in Jun-Jul 2026 (~$88k total) — aligns with bearish view but minimal. No congressional trades. Institutional: mixed — Victory Capital added 41.5%, Russell Investments added 55.9%, but Baillie Gifford nearly exited (-83.2%), Fifth Third trimmed 33.5%, PNC trimmed 50%. Short interest at 56.9% of float is extremely high, signaling heavy bearish positioning that could squeeze if price moves up. Overall, cross-platform signals are mixed but more bearish (insider sells, large institutional exits, high short interest).
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 12d ago | Institutional Cluster | $31.50 $33.68 | ▲ +6.92% | ▲ +7.94% | $33.24 (+5.52%) |
Aug 17, 2026 10w ago | Insider Cluster | $24.94 $24.74 | ▼ −0.80% | ▼ −0.60% | $33.24 (+33.28%) |
Aug 10, 2026 11w ago | ANALYST-DOWNGRADE | $25.63 $24.52 | ▲ +4.33% | ▲ +4.28% | $33.24 (−29.69%) |
Jul 15, 2026 14w ago | DEFA14A | $22.26 $20.49 | ▼ −7.95% | ▼ −6.97% | $33.24 (+49.33%) |
Jun 29, 2026 17w ago | ANALYST-DOWNGRADE | $20.59 $22.86 | ▼ −11.02% | ▼ −9.64% | $33.24 (−61.44%) |
Jun 18, 2026 18w ago | 3 | $20.07 $20.88 | ▲ +4.04% | ▲ +6.10% | $33.24 (+65.62%) |
Apr 17, 2026 27w ago | 8-K | $24.39 $24.66 | ▲ +1.11% | ▲ +0.19% | $33.24 (+36.29%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers